John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Cytek Biosciences
CTKB
$577M
| $5.65M | 0.02% |
+524,421
| New | +$7.08M |
|
852
Gibraltar Industries
ROCK
$1.37B
| $5.63M | 0.02% |
131,189
+123,468
| +1,599% | +$6.51M |
|
853
New Mountain Finance
NMFC
$722M
| $5.62M | 0.02% |
405,571
+85,608
| +27% | +$1.16M |
|
854
FNB Corp
FNB
$6.58B
| $5.62M | 0.02% |
451,056
-162,673
| -27% | -$2.14M |
|
855
Plug Power
PLUG
$3.03B
| $5.61M | 0.02% |
+195,945
| New | +$4.67M |
|
856
Travere Therapeutics
TVTX
$6.15B
| $5.58M | 0.02% |
216,587
+119,187
| +122% | +$3.16M |
|
857
Workhorse Group
WKHS
$34.1M
| $5.58M | 0.02% |
372
+68
| +22% | +$750K |
|
858
Aspen Aerogels
ASPN
$416M
| $5.57M | 0.02% |
+161,539
| New | +$5.24M |
|
859
Halozyme
HALO
$12.3B
| $5.56M | 0.02% |
+139,362
| New | +$4.96M |
|
860
BJ's Restaurants
BJRI
$1.43B
| $5.52M | 0.02% |
195,048
+87,899
| +82% | +$2.67M |
|
861
Ziff Davis
ZD
$1.91B
| $5.5M | 0.02% |
+56,812
| New | +$5.82M |
|
862
iShares US Telecommunications ETF
IYZ
$1.27B
| $5.49M | 0.02% |
183,800
+171,200
| +1,359% | +$5.23M |
|
|
FRC
863
DELISTED
First Republic Bank
FRC
| $5.46M | 0.02% |
+33,676
| New | +$5.88M |
|
864
Moody's
MCO
$88.6B
| $5.45M | 0.02% |
16,152
-69,363
| -81% | -$23.3M |
|
865
Teleflex
TFX
$5.86B
| $5.42M | 0.02% |
15,268
-75,009
| -83% | -$24.7M |
|
|
TPTX
866
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $5.41M | 0.02% |
201,558
+190,569
| +1,734% | +$6.4M |
|
|
VRAY
867
DELISTED
ViewRay, Inc.
VRAY
| $5.41M | 0.02% |
1,379,965
+358,000
| +35% | +$1.52M |
|
|
MNDT
868
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.38M | 0.02% |
+241,343
| New | +$4.47M |
|
869
Maximus
MMS
$3.05B
| $5.38M | 0.02% |
71,775
+51,546
| +255% | +$3.94M |
|
|
NIU
870
Niu Technologies
NIU
$152M
| $5.38M | 0.02% |
556,839
-181,724
| -25% | -$2.28M |
|
871
PUT
Southwest Airlines
LUV
$19.9B
| $5.36M | 0.02% |
117,100
-31,700
| -21% | -$1.39M |
|
872
SLR Investment Corp
SLRC
$693M
| $5.36M | 0.02% |
295,798
+267,857
| +959% | +$4.9M |
|
|
DHC
873
Diversified Healthcare Trust
DHC
$1.94B
| $5.36M | 0.02% |
1,674,736
+1,163,734
| +228% | +$3.55M |
|
874
CACI
CACI
$14.1B
| $5.36M | 0.02% |
17,780
+12,355
| +228% | +$3.41M |
|
875
Methanex
MEOH
$4.57B
| $5.34M | 0.02% |
97,911
-17,933
| -15% | -$877K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.